Cargando…

Landscape of Cardiovascular Device Registries in the United States

BACKGROUND: Regulators increasingly rely on registries for decision making related to high‐risk medical devices in the United States. However, the limited uniform standards for registries may create substantial variability in registry implementation and utility to regulators. We surveyed the current...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajan, Prashant V., Holtzman, Jessica N., Kesselheim, Aaron S., Yeh, Robert W., Kramer, Daniel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585371/
https://www.ncbi.nlm.nih.gov/pubmed/31433706
http://dx.doi.org/10.1161/JAHA.119.012756
_version_ 1783428696273584128
author Rajan, Prashant V.
Holtzman, Jessica N.
Kesselheim, Aaron S.
Yeh, Robert W.
Kramer, Daniel B.
author_facet Rajan, Prashant V.
Holtzman, Jessica N.
Kesselheim, Aaron S.
Yeh, Robert W.
Kramer, Daniel B.
author_sort Rajan, Prashant V.
collection PubMed
description BACKGROUND: Regulators increasingly rely on registries for decision making related to high‐risk medical devices in the United States. However, the limited uniform standards for registries may create substantial variability in registry implementation and utility to regulators. We surveyed the current landscape of US cardiovascular device registries and chart the extent of inconsistency in goals, administration, enrollment procedures, and approach to data access. METHODS AND RESULTS: A systematic review using Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) guidelines identified studies (1995–2017) referencing cardiovascular device registries with a US‐based institution. Registries were then evaluated by reviewing associated articles and websites. Extracted data included device type, primary scientific aim(s), funding, stewardship (eg, administration of registry procedures), enrollment procedures, informed consent process, and mechanisms to access data for research. The 138 cardiovascular device registries in the cohort covered devices addressing interventional cardiology (65.9%), arrhythmias (15.2%), heart failure (10.1%), and valvular disease (10.1%). While the majority (55.8%) were industry‐funded, stewardship was predominantly overseen by academic centers (74.0%). Most registry participation was voluntary (77.5%), but a substantial minority (19.7%) were required as a condition of device implantation. Informed consent requirements varied widely, with written consent required in only 55.1% of registries. Registry data were primarily accessible only to stewards (84.1%), with 13.8% providing pathways for external applications. CONCLUSIONS: The majority of cardiovascular device registries were funded privately under the auspices of academic institutions, which set the rules for data access. The substantial variation between cardiovascular device registries suggests a role for regulators to further strengthen guidelines to improve quality, consistency, and ethical standards.
format Online
Article
Text
id pubmed-6585371
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65853712019-06-27 Landscape of Cardiovascular Device Registries in the United States Rajan, Prashant V. Holtzman, Jessica N. Kesselheim, Aaron S. Yeh, Robert W. Kramer, Daniel B. J Am Heart Assoc Original Research BACKGROUND: Regulators increasingly rely on registries for decision making related to high‐risk medical devices in the United States. However, the limited uniform standards for registries may create substantial variability in registry implementation and utility to regulators. We surveyed the current landscape of US cardiovascular device registries and chart the extent of inconsistency in goals, administration, enrollment procedures, and approach to data access. METHODS AND RESULTS: A systematic review using Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) guidelines identified studies (1995–2017) referencing cardiovascular device registries with a US‐based institution. Registries were then evaluated by reviewing associated articles and websites. Extracted data included device type, primary scientific aim(s), funding, stewardship (eg, administration of registry procedures), enrollment procedures, informed consent process, and mechanisms to access data for research. The 138 cardiovascular device registries in the cohort covered devices addressing interventional cardiology (65.9%), arrhythmias (15.2%), heart failure (10.1%), and valvular disease (10.1%). While the majority (55.8%) were industry‐funded, stewardship was predominantly overseen by academic centers (74.0%). Most registry participation was voluntary (77.5%), but a substantial minority (19.7%) were required as a condition of device implantation. Informed consent requirements varied widely, with written consent required in only 55.1% of registries. Registry data were primarily accessible only to stewards (84.1%), with 13.8% providing pathways for external applications. CONCLUSIONS: The majority of cardiovascular device registries were funded privately under the auspices of academic institutions, which set the rules for data access. The substantial variation between cardiovascular device registries suggests a role for regulators to further strengthen guidelines to improve quality, consistency, and ethical standards. John Wiley and Sons Inc. 2019-06-01 /pmc/articles/PMC6585371/ /pubmed/31433706 http://dx.doi.org/10.1161/JAHA.119.012756 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Rajan, Prashant V.
Holtzman, Jessica N.
Kesselheim, Aaron S.
Yeh, Robert W.
Kramer, Daniel B.
Landscape of Cardiovascular Device Registries in the United States
title Landscape of Cardiovascular Device Registries in the United States
title_full Landscape of Cardiovascular Device Registries in the United States
title_fullStr Landscape of Cardiovascular Device Registries in the United States
title_full_unstemmed Landscape of Cardiovascular Device Registries in the United States
title_short Landscape of Cardiovascular Device Registries in the United States
title_sort landscape of cardiovascular device registries in the united states
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585371/
https://www.ncbi.nlm.nih.gov/pubmed/31433706
http://dx.doi.org/10.1161/JAHA.119.012756
work_keys_str_mv AT rajanprashantv landscapeofcardiovasculardeviceregistriesintheunitedstates
AT holtzmanjessican landscapeofcardiovasculardeviceregistriesintheunitedstates
AT kesselheimaarons landscapeofcardiovasculardeviceregistriesintheunitedstates
AT yehrobertw landscapeofcardiovasculardeviceregistriesintheunitedstates
AT kramerdanielb landscapeofcardiovasculardeviceregistriesintheunitedstates